145 related articles for article (PubMed ID: 32127902)
1. Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya.
Ndede I; Mining SK; Patel K; Wanjala FM; Tenge C
Afr Health Sci; 2019 Dec; 19(4):3242-3248. PubMed ID: 32127902
[TBL] [Abstract][Full Text] [Related]
2. Epstein barr virus IgG and EBER-1 in Burkitt's lymphoma children at a referral hospital in western Kenya.
Ndede I; Mining SK; Patel K; Wanjala FM; Tenge CN
Pan Afr Med J; 2019; 34():206. PubMed ID: 32180880
[TBL] [Abstract][Full Text] [Related]
3. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
Tamaru J; Hummel M; Marafioti T; Kalvelage B; Leoncini L; Minacci C; Tosi P; Wright D; Stein H
Am J Pathol; 1995 Nov; 147(5):1398-407. PubMed ID: 7485402
[TBL] [Abstract][Full Text] [Related]
4. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes.
Klein U; Klein G; Ehlin-Henriksson B; Rajewsky K; Küppers R
Mol Med; 1995 Jul; 1(5):495-505. PubMed ID: 8529116
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis.
Baptista MJ; Calpe E; Fernandez E; Colomo L; Cardesa-Salzmann TM; Abrisqueta P; Bosch F; Crespo M
Leuk Res; 2014 Apr; 38(4):509-15. PubMed ID: 24480549
[TBL] [Abstract][Full Text] [Related]
6. Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis.
Chapman CJ; Wright D; Stevenson FK
Leuk Lymphoma; 1998 Jul; 30(3-4):257-67. PubMed ID: 9713958
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
8. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity.
Chapman CJ; Mockridge CI; Rowe M; Rickinson AB; Stevenson FK
Blood; 1995 Apr; 85(8):2176-81. PubMed ID: 7718888
[TBL] [Abstract][Full Text] [Related]
9. VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection.
Chapman CJ; Zhou JX; Gregory C; Rickinson AB; Stevenson FK
Blood; 1996 Nov; 88(9):3562-8. PubMed ID: 8896424
[TBL] [Abstract][Full Text] [Related]
10. The absence of ongoing immunoglobulin gene hypermutation suggests a distinct mechanism for c-myc mutation in endemic Burkitt's lymphoma.
Cowley CG; Carroll WL; Johnston JM
J Pediatr Hematol Oncol; 1996 Feb; 18(1):29-35. PubMed ID: 8556366
[TBL] [Abstract][Full Text] [Related]
11. Diversity and somatic hypermutation of the Ig VHDJH, V kappa J kappa, and V lambda J lambda gene segments in lymphoma B cells: relevance to the origin of the neoplastic B cell clone.
Riboldi P; Ikematsu W; Brambilla B; Caprani C; Gerosa M; Casali P
Hum Immunol; 2003 Jan; 64(1):69-81. PubMed ID: 12507816
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells.
Harris RS; Croom-Carter DS; Rickinson AB; Neuberger MS
J Virol; 2001 Nov; 75(21):10488-92. PubMed ID: 11581418
[TBL] [Abstract][Full Text] [Related]
13. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis.
Scholtysik R; Kreuz M; Klapper W; Burkhardt B; Feller AC; Hummel M; Loeffler M; Rosolowski M; Schwaenen C; Spang R; Stein H; Thorns C; Trümper L; Vater I; Wessendorf S; Zenz T; Siebert R; Küppers R;
Haematologica; 2010 Dec; 95(12):2047-55. PubMed ID: 20823134
[TBL] [Abstract][Full Text] [Related]
14. V(H) gene analysis of Burkitt's lymphoma in children from north-western Iran.
Chapman CJ; Wright D; Feizi HP; Davis Z; Stevenson FK
Br J Haematol; 1998 Dec; 103(4):1116-23. PubMed ID: 9886329
[TBL] [Abstract][Full Text] [Related]
15. Biased utilization of immunoglobulin variable region heavy- and light-chain genes by the malignant CD5- B lymphocytes from patients with Burkitt's lymphoma.
Moazzeni M; Mosayyebi G; Stevenson FK; Abbot S; Mageed RA; Shokri F
Int J Cancer; 1994 Jul; 58(2):226-32. PubMed ID: 7517918
[TBL] [Abstract][Full Text] [Related]
16. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
17. c-myc hypermutation in Burkitt's lymphoma.
Johnston JM; Carroll WL
Leuk Lymphoma; 1992 Dec; 8(6):431-9. PubMed ID: 1297477
[TBL] [Abstract][Full Text] [Related]
18. Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.
Riboldi P; Gaidano G; Schettino EW; Steger TG; Knowles DM; Dalla-Favera R; Casali P
Blood; 1994 May; 83(10):2952-61. PubMed ID: 8180391
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of Burkitt's lymphoma from three regions in Kenya.
Mwanda WO; Orem J; Remick SC; Rochford R; Whalen C; Wilson ML
East Afr Med J; 2005 Sep; 82(9 Suppl):S135-43. PubMed ID: 16619689
[TBL] [Abstract][Full Text] [Related]
20. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
